James O'Hara
Psychiatric/Mental Health · Phoenix, AZNPI 1427675222
Payments from drug & device makers
Across 102 payments — averaging $19.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$338
- AbbVie$250
- Alkermes, Inc.$230
- Axsome Therapeutics, Inc.$203
- Johnson & Johnson$135
- Neurocrine Biosciences, Inc.$125
- plus $686 from 11 others
What the payments were for
- Food & beverage$1,967100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 17 | $338 |
| AbbVie | 19 | $250 |
| Alkermes, Inc. | 10 | $230 |
| Axsome Therapeutics, Inc. | 10 | $203 |
| Johnson & Johnson | 5 | $135 |
| Neurocrine Biosciences, Inc. | 6 | $125 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $107 |
| Corium, LLC | 4 | $82 |
| Ironshore Pharmaceuticals Inc. | 4 | $81 |
| Bausch Health US, LLC | 5 | $77 |
| Lundbeck LLC | 4 | $72 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Tris Pharma Inc | 3 | $41 |
| Biogen | 1 | $27 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
How this compares
$1,967 in reported general payments places this provider in the 80th percentile of 1,230 psychiatric/mental health providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Divalproex Sodium ErDivalproex Sodium | 62 | $6,066 |
| Aripiprazole | 37 | $4,421 |
| Quetiapine Fumarate | 71 | $2,366 |
| Ziprasidone Hcl | 24 | $1,710 |
| Clozapine | 11 | $1,690 |
| Risperidone | 69 | $1,474 |
| Trazodone Hcl | 54 | $674 |
| Buspirone Hcl | 24 | $641 |
| Sertraline Hcl | 36 | $581 |
| Benztropine Mesylate | 39 | $556 |
| Olanzapine | 15 | $377 |
| Lamotrigine | 23 | $344 |
| Escitalopram Oxalate | 23 | $338 |
| Hydroxyzine Hcl | 11 | $304 |
| Bupropion XlBupropion Hcl | 13 | $265 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Phoenix
- Elizabeth ElliottPhoenix$363K
- Russell HorningPhoenix$254K
- Claire ReecePhoenix$88K
- Luis FongPhoenix$59K
- Marilizabeth BirkPhoenix$34K
- Jaime LecomtePhoenix$15K
- Roger MayorgaPhoenix$10K
- Elena SassPhoenix$9K
- Martha SerranoPhoenix$8K
- Bonnie VogesPhoenix$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.